NFG
IMRX icon

Nations Financial Group’s Immuneering IMRX Stock Holding History

Nations Financial Group’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$89.6K Buy
17,000
+1,000
+6% +$5.13K ﹤0.01% 763
2025
Q4 		$105K Buy
+16,000
New +$103K 0.01% 738

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Nations Financial Group's IMRX Position: Q1 2026 in Review

Nations Financial Group increased its Immuneering (IMRX) stake by 6.3% in Q1 2026, buying an estimated $5.13K and bringing the position to 17,000 shares worth $89.6K. The position accounts for ﹤0.01% of the portfolio, ranked #763.

Nations Financial Group first reported a position in IMRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $105K in Q4 2025. 95 funds tracked by Wall St. Rank hold IMRX as of Q1 2026.

  • Nations Financial Group held 17,000 shares of Immuneering worth $89.6K as of Q1 2026.
  • Nations Financial Group bought 1,000 Immuneering shares in Q1 2026, an estimated $5.13K.
  • Immuneering made up ﹤0.01% of Nations Financial Group's portfolio in Q1 2026, its #763 holding.
  • Nations Financial Group first reported a position in Immuneering in Q4 2025 and has held it in 2 quarters since.
  • Nations Financial Group's Immuneering position peaked at $105K in Q4 2025.
  • 95 funds tracked by Wall St. Rank held Immuneering as of Q1 2026.

Based on Nations Financial Group's 13F filing for Q1 2026, filed 15 Apr 2026.